Selected research
Industry Research
Metronidazole Injection Industry Research Report 2026
Market perspective
The global Metronidazole Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Metronidazole Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Metronidazole Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Metronidazole Injection include Pfizer, Baxter, Unique Pharmaceuticals, Sanofi-Aventis Canada Inc, Sagent Pharmaceuticals, Qatar Pharma, JB Chemicals and Pharmaceuticals, B. Braun Medical Inc and AdvaCare Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Metronidazole Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Metronidazole Injection Market by Company
Pfizer
Baxter
Unique Pharmaceuticals
Sanofi-Aventis Canada Inc
Sagent Pharmaceuticals
Qatar Pharma
JB Chemicals and Pharmaceuticals
B. Braun Medical Inc
AdvaCare Pharma
Metronidazole Injection Segment by Type
500mg/100mL
50mg/10mL
Metronidazole Injection Segment by Application
Adult Use
Pediatric Use
Geriatric Use
Metronidazole Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metronidazole Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metronidazole Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metronidazole Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Metronidazole Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Metronidazole Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Metronidazole Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 500mg/100mL
- 50mg/10mL
Applications
- Adult Use
- Pediatric Use
- Geriatric Use
Companies covered
- Pfizer
- Baxter
- Unique Pharmaceuticals
- Sanofi-Aventis Canada Inc
- Sagent Pharmaceuticals
- Qatar Pharma
- JB Chemicals and Pharmaceuticals
- B. Braun Medical Inc
- AdvaCare Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Metronidazole Injection Market Size (2021-2032)
- 2.2.2 Global Metronidazole Injection Sales (2021-2032)
- 2.2.3 Global Metronidazole Injection Market Average Price (2021-2032)
- 2.3 Metronidazole Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 500mg/100mL
- 2.3.3 50mg/10mL
- 2.4 Metronidazole Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult Use
- 2.4.3 Pediatric Use
- 2.4.4 Geriatric Use
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Metronidazole Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Metronidazole Injection Sales (K L) of Manufacturers (2021-2026)
- 3.3 Global Metronidazole Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Metronidazole Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Metronidazole Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Metronidazole Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Metronidazole Injection, Product Type & Application
- 3.8 Global Manufacturers of Metronidazole Injection, Established Date
- 3.9 Global Metronidazole Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Metronidazole Injection Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 Baxter
- 4.2.1 Baxter Company Information
- 4.2.2 Baxter Business Overview
- 4.2.3 Baxter Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baxter Metronidazole Injection Product Portfolio
- 4.2.5 Baxter Recent Developments
- 4.3 Unique Pharmaceuticals
- 4.3.1 Unique Pharmaceuticals Company Information
- 4.3.2 Unique Pharmaceuticals Business Overview
- 4.3.3 Unique Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Unique Pharmaceuticals Metronidazole Injection Product Portfolio
- 4.3.5 Unique Pharmaceuticals Recent Developments
- 4.4 Sanofi-Aventis Canada Inc
- 4.4.1 Sanofi-Aventis Canada Inc Company Information
- 4.4.2 Sanofi-Aventis Canada Inc Business Overview
- 4.4.3 Sanofi-Aventis Canada Inc Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sanofi-Aventis Canada Inc Metronidazole Injection Product Portfolio
- 4.4.5 Sanofi-Aventis Canada Inc Recent Developments
- 4.5 Sagent Pharmaceuticals
- 4.5.1 Sagent Pharmaceuticals Company Information
- 4.5.2 Sagent Pharmaceuticals Business Overview
- 4.5.3 Sagent Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sagent Pharmaceuticals Metronidazole Injection Product Portfolio
- 4.5.5 Sagent Pharmaceuticals Recent Developments
- 4.6 Qatar Pharma
- 4.6.1 Qatar Pharma Company Information
- 4.6.2 Qatar Pharma Business Overview
- 4.6.3 Qatar Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Qatar Pharma Metronidazole Injection Product Portfolio
- 4.6.5 Qatar Pharma Recent Developments
- 4.7 JB Chemicals and Pharmaceuticals
- 4.7.1 JB Chemicals and Pharmaceuticals Company Information
- 4.7.2 JB Chemicals and Pharmaceuticals Business Overview
- 4.7.3 JB Chemicals and Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 JB Chemicals and Pharmaceuticals Metronidazole Injection Product Portfolio
- 4.7.5 JB Chemicals and Pharmaceuticals Recent Developments
- 4.8 B. Braun Medical Inc
- 4.8.1 B. Braun Medical Inc Company Information
- 4.8.2 B. Braun Medical Inc Business Overview
- 4.8.3 B. Braun Medical Inc Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 B. Braun Medical Inc Metronidazole Injection Product Portfolio
- 4.8.5 B. Braun Medical Inc Recent Developments
- 4.9 AdvaCare Pharma
- 4.9.1 AdvaCare Pharma Company Information
- 4.9.2 AdvaCare Pharma Business Overview
- 4.9.3 AdvaCare Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AdvaCare Pharma Metronidazole Injection Product Portfolio
- 4.9.5 AdvaCare Pharma Recent Developments
5 Global Metronidazole Injection Market Scenario by Region
- 5.1 Global Metronidazole Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Metronidazole Injection Sales by Region: 2021-2032
- 5.2.1 Global Metronidazole Injection Sales by Region: 2021-2026
- 5.2.2 Global Metronidazole Injection Sales by Region: 2027-2032
- 5.3 Global Metronidazole Injection Revenue by Region: 2021-2032
- 5.3.1 Global Metronidazole Injection Revenue by Region: 2021-2026
- 5.3.2 Global Metronidazole Injection Revenue by Region: 2027-2032
- 5.4 North America Metronidazole Injection Market Facts & Figures by Country
- 5.4.1 North America Metronidazole Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Metronidazole Injection Sales by Country (2021-2032)
- 5.4.3 North America Metronidazole Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Metronidazole Injection Market Facts & Figures by Country
- 5.5.1 Europe Metronidazole Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Metronidazole Injection Sales by Country (2021-2032)
- 5.5.3 Europe Metronidazole Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Metronidazole Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Metronidazole Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Metronidazole Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Metronidazole Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Metronidazole Injection Market Facts & Figures by Country
- 5.7.1 South America Metronidazole Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Metronidazole Injection Sales by Country (2021-2032)
- 5.7.3 South America Metronidazole Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Metronidazole Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Metronidazole Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Metronidazole Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Metronidazole Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Metronidazole Injection Sales by Type (2021-2032)
- 6.1.1 Global Metronidazole Injection Sales by Type (2021-2032) & (K L)
- 6.1.2 Global Metronidazole Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Metronidazole Injection Revenue by Type (2021-2032)
- 6.2.1 Global Metronidazole Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Metronidazole Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Metronidazole Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Metronidazole Injection Sales by Application (2021-2032)
- 7.1.1 Global Metronidazole Injection Sales by Application (2021-2032) & (K L)
- 7.1.2 Global Metronidazole Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Metronidazole Injection Revenue by Application (2021-2032)
- 7.2.1 Global Metronidazole Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Metronidazole Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Metronidazole Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Metronidazole Injection Value Chain Analysis
- 8.1.1 Metronidazole Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Metronidazole Injection Production Mode & Process
- 8.2 Metronidazole Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Metronidazole Injection Distributors
- 8.2.3 Metronidazole Injection Customers
9 Global Metronidazole Injection Analyzing Market Dynamics
- 9.1 Metronidazole Injection Industry Trends
- 9.2 Metronidazole Injection Industry Drivers
- 9.3 Metronidazole Injection Industry Opportunities and Challenges
- 9.4 Metronidazole Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst